Exercise or conversion by David Persing of 3 shares of Cepheid subject to Rule 16b-3
Cepheid insider trading alert for exercise of common stock by David Persing, Exec VPChief MedTech Officer, on October 7, 2017. This event was filed by Cepheid with SEC on 2011-11-01. SEC Form: Changes in beneficial ownership. David Persing is currently serves as executive vice president chief medical and technology officer, director of Cepheid
Filed transaction by Cepheid director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
Story MomentumThis story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.
Similar stores for Cepheid